BlackRock Fund Advisors - ACURA PHARMACEUTICALS INC ownership

ACURA PHARMACEUTICALS INC's ticker is ACUR and the CUSIP is 00509L703. A total of 30 filers reported holding ACURA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 7.65 and the average weighting 0.4%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of ACURA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$34,000
+70.0%
42,610
-6.4%
0.00%
Q4 2014$20,000
-39.4%
45,506
+7.7%
0.00%
Q3 2014$33,000
-32.7%
42,248
-6.8%
0.00%
Q2 2014$49,000
-23.4%
45,325
+2.9%
0.00%
Q1 2014$64,000
-1.5%
44,029
+13.8%
0.00%
Q4 2013$65,000
-7.1%
38,683
+4.4%
0.00%
Q3 2013$70,000
+9.4%
37,063
+8.5%
0.00%
Q2 2013$64,00034,1470.00%
Other shareholders
ACURA PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 10,294,886$14,282,0003.64%
FAS Wealth Partners, Inc. 81,983$120,0000.08%
Rotella Capital Management, Inc. 15,976$23,0000.03%
INTRUST BANK NA 23,960$35,0000.01%
CORTLAND ASSOCIATES INC/MO 39,050$57,0000.01%
Mariner, LLC 52,018$76,0000.01%
Spark Investment Management LLC 29,300$42,0000.01%
COMMERCE BANK 89,400$131,0000.00%
Hodges Capital Management Inc. 28,950$42,0000.00%
OPPENHEIMER & CO INC 55,000$80,0000.00%
View complete list of ACURA PHARMACEUTICALS INC shareholders